Immunosuppressive adjuvant therapy for pemphigus

Yihuan Yao,Jiongke Wang,Kui Zhao,Yujie Shi,Xin Zeng,Qianming Chen
DOI: https://doi.org/10.7518/gjkq.2018.02.007
2018-01-01
Abstract:Pemphigus is a severe, chronic, autoimmune bullous disease that affects the skin and mucous membranes. To date, glucocorticoidis the first treatment medicine for pemphigus. Nevertheless, the use of glucocorticoid may result in adverse effects during treatment of this disease. Therefore, several immunosuppressive adjuvant therapies or non-medicinal therapies should be adopted to relieve the side effects of glucocorticoid. Thus, we reviewed the immunosuppressive therapy in this article.
What problem does this paper attempt to address?